Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 116.73
-0.67 (-0.57%)
At close: Oct 9, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 108.86 billion as of October 10, 2025. Its market cap has increased by 39.65% in one year.
Market Cap
108.86B
Enterprise Value
121.50B
Revenue
21.07B
Ranking
n/a
PE Ratio
23.63
Stock Price
116.73
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 108.86B, an increase of 78,366.98%. That is a compound annual growth rate of 21.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 108.91B | 18.45% |
| Dec 31, 2024 | 91.95B | 16.03% |
| Dec 29, 2023 | 79.25B | -11.32% |
| Dec 30, 2022 | 89.37B | 32.86% |
| Dec 31, 2021 | 67.26B | 25.75% |
| Dec 31, 2020 | 53.49B | -13.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| HSBC Holdings | 173.70B |
| Shell | 161.14B |
| Unilever | 110.07B |
| Rolls-Royce Holdings | 97.26B |
| Rio Tinto Group | 86.56B |
| British American Tobacco p.l.c. | 83.51B |
| BP p.l.c. | 66.68B |